OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
March 02, 2023
Decreasing vein to vein time saves lives.
February 02, 2023
In vivo CAR-T gene therapies could overcome the challenges faced by autologous and allogeneic treatments.
September 14, 2022
An early drug candidate screening strategy should incorporate clear targets to lessen late-stage failure.
August 10, 2022
Preclinical testing is better able to evaluate complex drug candidates thanks to innovations in animal model approaches.
June 13, 2022
Precision BioSciences has released clinical trial data on CAR T therapy candidates PBCAR0191, PBCAR19B, and PBCAR269A.
May 16, 2022
To build trust and ensure a high-quality product, companies must be sure their contracts are firm and their lines of communication even firmer.
March 09, 2022
New technologies are treatments are emerging to tackle COVID-19 and its assortment of new variants.
March 08, 2022
Key challenges posed to autologous and allogeneic treatments could be resolved by in-vivo CAR-T gene therapies.
January 02, 2022
Although mRNA and viral vector vaccines have been top of mind for COVID-19 treatments, other technologies and treatments are emerging—along with new variants.
December 09, 2021
Sanofi’s acquisition of Origimm Biotechnology will add to its pipeline of vaccine candidates for treating acne.